Literature DB >> 2871844

Effect of ibopamine on diuresis and arterial blood pressure in anesthetized rats and its interactions with dopaminergic and alpha- and beta-adrenergic antagonists.

R Ferrini, G Miragoli.   

Abstract

The present paper reports a study of the effect of ibopamine (SB-7505), the 3,4-diisobutyryl ester of N-methyldopamine (epinine), on diuresis and blood pressure in anesthetized rats. The results obtained demonstrate that ibopamine, administered orally at doses of 12.5 to 200 mg/kg, caused a dose-dependent diuresis. The increase in blood pressure was moderate and of short duration. The diuretic effect of ibopamine was antagonized by d-sulpiride, haloperidol, bulbocapnine and phenoxybenzamine, but not by l-sulpiride and l-propranolol. The increase in blood pressure was antagonized by phenoxybenzamine only. The diuretic effect of ibopamine in rats reflects agonist activity at dopamine receptors and, in part, alpha-adrenoceptors and is independent of beta-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2871844

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  3 in total

1.  Early cardiovascular changes with ibopamine: evidence for a biphasic haemodynamic action.

Authors:  K J Hogg; R S Hornung; C A Howie; W S Hillis
Journal:  Br J Clin Pharmacol       Date:  1987-10       Impact factor: 4.335

Review 2.  Ibopamine. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.

Authors:  J M Henwood; P A Todd
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

3.  Neurohumoral and hemodynamic effects of ibopamine in a rat model of chronic myocardial infarction and heart failure.

Authors:  D J van Veldhuisen; W H van Gilst; B J de Smet; P A de Graeff; E Scholtens; H Buikema; A R Girbes; H Wesseling; K I Lie
Journal:  Cardiovasc Drugs Ther       Date:  1994-04       Impact factor: 3.727

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.